QGEN 📈 Qiagen - Overview

Qiagen N.V. is a leading provider of sample to insight solutions, enabling the transformation of biological materials into molecular insights that drive informed decision-making. The company's comprehensive portfolio includes sample technology consumables, such as nucleic stabilization and purification kits, which are designed to extract and preserve high-quality nucleic acids from various sample materials. Additionally, Qiagen offers manual and automated processing solutions for genotyping, gene expression, and viral and bacterial analysis, leveraging advanced technologies like silica membranes and magnetic bead technologies to streamline workflows and enhance results.

Qiagen's product lineup also encompasses secondary sample technology consumables, including kits and components for the purification of nucleic acids from secondary sample materials. The company's instrument portfolio features a range of devices for nucleic acid purification and accessories, supporting various applications, from research and development to clinical diagnostics. Furthermore, Qiagen provides a suite of assays for diverse applications, including interferon-gamma release assay for TB testing, post-transplant testing, viral load monitoring, prenatal testing, and detection of sexually transmitted diseases and HPV. These assays are designed to facilitate the analysis of genomic variants, such as mutations, insertions, deletions, and fusions, and are complemented by sample to insight instruments that enable one-step molecular analysis of hard-to-diagnose syndromes and integrated PCR testing.

The company's PCR consumables, including quantitative PCR, reverse transcription, and combinations kits, support the analysis of gene expression, genotyping, and gene regulation, and are optimized for use with Qiagen instruments and technologies. Qiagen also offers human ID and forensics assay consumables, such as STR assays for human ID, and assays for food contamination, as well as digital PCR and qPCR solutions. Moreover, the company has developed and configured enzymes and PCR solutions to cater to specific customer needs. Qiagen's predefined and custom NGS gene panels, library prep kits and components, and whole genome amplification solutions support a range of next-generation sequencing applications, while its bioinformatics solutions and custom laboratory and genomic services provide additional value to customers.

Qiagen serves a diverse customer base, including molecular diagnostics, academia, pharmaceutical, and applied testing customers, and has established collaborations with prominent organizations, such as the U.S. FBI and Bio-Manguinhos/Fiocruz, to detect malaria and dengue. Founded in 1984 and headquartered in Venlo, the Netherlands, Qiagen has established itself as a trusted partner in the life sciences industry, with a strong online presence at https://www.qiagen.com and a common stock listing (ISIN: NL0015001WM6) in the Life Sciences Tools & Services sub-industry.